Physician
Pedcare, PA
Pedcare, PA was paid $16.35M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoPEDCARE, PA
MESQUITE, TX 75150
MESQUITE, TX 75150
33aNPI1417177841assigned 04/26/2007
33bProvider typePediatrics Physician
28Total paid$16.35M
24GClaims1,128,425
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#13 of 1,136
Median peer was paid$329K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,287 | $236K | |
| 2019 | 10,305 | $257K | |
| 2020 | 108,365 | $784K | |
| 2021 | 289,780 | $3.20M | |
| 2022 | 265,793 | $4.32M | |
| 2023 | 251,212 | $4.06M | |
| 2024incomplete | 193,683 | $3.50M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 165,295 | 154,827 | $3.40M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 15% | 47,806 | 47,543 | $2.40M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 50,625 | 50,267 | $2.14M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 12% | 34,054 | 33,874 | $1.89M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.6% | 37,741 | 35,858 | $1.57M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.0% | 209,071 | 101,068 | $1.31M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.8% | 37,698 | 36,486 | $955K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 51,551 | 50,665 | $394K |
| 99381 | 2.4% | 7,640 | 7,519 | $391K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.4% | 10,279 | 10,077 | $386K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 35,384 | 17,436 | $288K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 26,732 | 26,483 | $184K |
82 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.0% | 36,179 | $166K |
| 99383 | <1% | 2,638 | $147K | |
| 90461 | <1% | 35,762 | $136K | |
| 99382 | <1% | 1,609 | $86K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,179 | $81K |
| 99384 | <1% | 1,025 | $56K | |
| 0071A | <1% | 1,959 | $52K | |
| 0072A | <1% | 1,717 | $46K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,816 | $34K |
| 99429 | <1% | 2,970 | $27K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,740 | $22K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,270 | $22K |
| 87807 | <1% | 3,671 | $19K | |
| 83655 | <1% | 4,192 | $15K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 578 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,503 | $10K |
| 0002A | <1% | 363 | $10K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 360 | $9K |
| 0001A | <1% | 321 | $9K | |
| 81003 | <1% | 8,419 | $9K | |
| 92551 | <1% | 7,483 | $8K | |
| 92552 | <1% | 3,055 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 202 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 849 | $6K |
| 69210 | <1% | 212 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 71 | $4K |
| 99050 | <1% | 1,460 | $4K | |
| 0081A | <1% | 162 | $4K | |
| 0082A | <1% | 139 | $4K | |
| 94760 | <1% | 7,878 | $4K | |
| 17110 | <1% | 50 | $3K | |
| 0003A | <1% | 99 | $2K | |
| 0073A | <1% | 52 | $1K | |
| 96380 | <1% | 65 | $1K | |
| 96160 | <1% | 357 | $1K | |
| 85027 | <1% | 523 | $1K | |
| 86703 | <1% | 391 | $979.63 | |
| 69209 | <1% | 112 | $972.86 | |
| 85014 | <1% | 1,751 | $769.18 | |
| 85018 | <1% | 1,768 | $732.31 | |
| 90473 | <1% | 105 | $547.23 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 37 | $325.19 |
| 90677 | <1% | 6,549 | $270.09 | |
| 90619 | <1% | 7,217 | $206.04 | |
| 86580 | <1% | 31 | $158.58 | |
| 94761 | <1% | 605 | $111.24 | |
| 82016 | <1% | 669 | $70.15 | |
| 0154A | <1% | 28 | $40.00 | |
| 0124A | <1% | 27 | $40.00 | |
| 90744 | <1% | 16,890 | $25.61 | |
| 90671 | <1% | 5,439 | $23.68 | |
| 96381 | <1% | 21 | $16.56 | |
| 82128 | <1% | 526 | $12.72 | |
| 99173 | <1% | 19,050 | $1.91 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 696 | $0.39 |
| 90686 | <1% | 35,421 | $0.32 | |
| 90656 | <1% | 3,492 | $0.09 | |
| 90620 | <1% | 6,161 | $0.02 | |
| 90651 | <1% | 16,580 | $0.01 | |
| 90381 | <1% | 137 | $0.01 | |
| 90698 | 0% | 32,458 | $0.00 | |
| 90696 | 0% | 7,145 | $0.00 | |
| 91307 | 0% | 1,760 | $0.00 | |
| 36416 | 0% | 10,271 | $0.00 | |
| 90680 | 0% | 15,144 | $0.00 | |
| 90716 | 0% | 6,682 | $0.00 | |
| 91315 | 0% | 27 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 14 | $0.00 |
| 90633 | 0% | 18,362 | $0.00 | |
| 90710 | 0% | 10,844 | $0.00 | |
| 94664 | 0% | 950 | $0.00 | |
| 90681 | 0% | 3,294 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 1,276 | $0.00 |
| 90707 | 0% | 6,613 | $0.00 | |
| 90670 | 0% | 19,735 | $0.00 | |
| 90715 | 0% | 6,283 | $0.00 | |
| 90734 | 0% | 5,082 | $0.00 | |
| 99051 | 0% | 600 | $0.00 | |
| 90380 | 0% | 32 | $0.00 | |
| 91308 | 0% | 155 | $0.00 | |
| 91300 | 0% | 176 | $0.00 | |
| 91312 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAFONTAINE, MONA (MANAGER)